Related posts
S&P hits another high, earnings hits and missesYields up, earnings good, stocks wobbleMarkets soar on earningsThis summary was created by AI, based on 24 opinions in the last 12 months.
Experts have mixed opinions on IBM Common Stock. Some see it as a legacy name that is adapting well and focusing on services, subscriptions and AI through Watson. Others are optimistic about its potential with Red Hat and Watson X. However, there are concerns about its growth potential and management's ability to execute. Overall, there is uncertainty about its future performance.
It has languished for many years compared to others in the same field. It has run up recently due to the AI frenzy/opportunity but there has been no big improvement in revenue and earnings. The largest component by far is consultation.
Legacy name that's trying to adapt. Now much more about services and subscriptions. Getting into AI through Watson, which long ago beat a world-class chess player and won a bunch of money on Jeopardy! Partnered with META and OpenAI. 18x earnings, not expensive. Good yield of 3.37%.
(Analysts’ price target is $183.38)Sold some AVGO to buy this recently. It trades at under 3x sales. Free cash flow has grown in the last 6 quarters from $7 billion to $12 billion, which he loves. Wants to see the 3% dividend grow. They get AI exposure through Red hat and Watson X. Shares have done nothing for 3-5 years, but the last quarter was excellent. It's old-school tech, but more conservative than AI stocks and is dividend-focused. It's not the old IBM. Very optimistic.
Pretty fairly priced, price target is $194.25. One of the first on the AI bandwagon with Watson. Pretty significant play in the cloud, especially with Red Hat acquisition. Spun off hardware, now a software company. Decent runway.
Price target raised, though it's below the current share price. As we move into cloud, big data and AI, the big winners are in data like IBM. IBM is old and sleepy, but they bought Red Hat and will be a winner in this space, though not flashy but rather slow and steady. Pays a nearly 4% as you wait.
Open architecture through Red Hat, highly appealing. Long shot, but a possibility, that it'll be able to develop an open architecture to make it competitive in AI. If yes, it's going much higher. Getting act together, getting rid of legacy divisions. Don't go wild, but he wouldn't argue strenuously against adding it as part of a well-balanced portfolio.
He's uncertain about the industry that NXST is in, but confident about IBM who delivered an excellent quarter.
First on the AI stage with "Watson", but fell short because of so many businesses. Much more a pure company now, that's why it's doing well and will be able to grow over next several years. Will benefit from cloud, but behind the leaders. He likes MSFT better, but IBM is cheaper.
AI has really played into its hands. Still has some of the legacy hardware. Short runway, take a bit of profit of about 1/3. If goes higher, you still own. If goes lower, you can buy it back.
(Analysts’ price target is $171.00)It's finally breathing some life into its stock. The 4.1% dividend is one factor, and falling interest rates will help. Their Q1 and Q2 saw sales lighter than expected, though posted big earnings beat. However, they beat revenues and earnings last month, plus strong cash flow. The CEO has been touting hybrid AI to clients. Their key AI platform is Watson X, launched last spring. Their consulting business makes up a third of revenues but is overlooked. Shares trades at only 16x PE 2024. 43% of sales are from software, and 33% from consulting. This is consistent. IBM its recent upgrades.
IBM lacks the spread of clientele like MSFT. Also, IBM has been getting rid of their hardware business, focusing more on software with AI. In terms of quality, MSFT is better (customer loyalty, Office Suite) while IBM is inferior, offering little growth. IBM isn't a big player moving forward. Among megatech, MSFT is the top.
Not a fan of company, however business is turning around. Dividend improving. Expecting 9% growth rate. Would wait to see how company performs before buying. Management team doing well.
Not a top pick for tech investing. Better options for investors in tech. Trading at fair price, but not getting excellent business.
Has done well, but medium- to long-term growth strategy is weak. Some decline in businesses. Made acquisitions at big premiums, impacting cashflow. Dividend won't grow much. Try for $120 or below, collect dividend, sell at peak. Layering in on MSFT over the next 6 months would be better.
Recent success. Nice beat last quarter, up 13% YOY. Flat revenue, general margins beat. 3-5% growth target. He models only 5% growth for 14x earnings. Dividend looks good. Better opportunities in tech and elsewhere.
IBM Common Stock is a American stock, trading under the symbol IBM-N on the New York Stock Exchange (IBM). It is usually referred to as NYSE:IBM or IBM-N
In the last year, 21 stock analysts published opinions about IBM-N. 10 analysts recommended to BUY the stock. 9 analysts recommended to SELL the stock. The latest stock analyst recommendation is . Read the latest stock experts' ratings for IBM Common Stock.
IBM Common Stock was recommended as a Top Pick by on . Read the latest stock experts ratings for IBM Common Stock.
Earnings reports or recent company news can cause the stock price to drop. Read stock experts’ recommendations for help on deciding if you should buy, sell or hold the stock.
21 stock analysts on Stockchase covered IBM Common Stock In the last year. It is a trending stock that is worth watching.
On 2024-03-18, IBM Common Stock (IBM-N) stock closed at a price of $191.69.